homosalate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbé, M; Doll, S; Grisard, E; Joliot, A; Jouve, M; Lavieu, G; Lescure, A; Martin-Jaular, L; Nery, ED; Nevo, N; Théry, C | 1 |
1 other study(ies) available for homosalate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Homosalate boosts the release of tumour-derived extracellular vesicles with protection against anchorage-loss property.
Topics: Dietary Supplements; Extracellular Vesicles; Humans; Salicylates; Triple Negative Breast Neoplasms | 2022 |